About this policy
CMS NCA document | source_status=Closed | review_type=5th Recon | public_comment_open=False | document_id=CAG-00085R5
Coverage indications
We have fully considered Boston Scientific Corporation’s request to reconsider our National Coverage Determination (NCD) on percutaneous transluminal angioplasty (PTA) with intracranial stent placement that is published at 20.7.B.5 of the Medicare National Coverage Determinations Manual. After considering additional evidence and information, including the timely public comments as required by §1862(1) of the Social Security Act, we are reaffirming our existing national coverage decision and will not expand coverage as requested. Medicare will continue to cover PTA and stenting of intracranial arteries for the treatment of cerebral artery stenosis ≥ 50% in patients with intracranial atherosclerotic disease when furnished in accordance with the FDA-approved protocols governing Category B IDE trials. CMS will continue our national non-coverage for all other indications for PTA with or without stenting to treat obstructive lesions of the vertebral and cerebral arteries.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.